Quality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapy
dc.contributor.author | Arslan, Fatma Tas | |
dc.contributor.author | Basbakkal, Zumrut | |
dc.contributor.author | Kantar, Mehmet | |
dc.date.accessioned | 2020-03-26T18:43:04Z | |
dc.date.available | 2020-03-26T18:43:04Z | |
dc.date.issued | 2013 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | This cross-sectional and descriptive study was designed to determine symptoms emerging due to chemotherapy treatment and their effects on children's quality of life. The research was carried out between February 2008 and February 2009 at the pediatric oncology clinics in four hospitals, focusing on 93 patients receiving chemotherapy. A survey form, the Pediatric Quality of Life Inventory (PedsQL 4.0) and the Memorial Symptom Assessment Scale (MSAS) were used as data collection tools. Chi-square and Student t tests were performed for data analysis. Some 51.6% of the children were aged 13-15 years old, and 51.8% were boys and 50.5% were diagnosed as having solid tumors. There were significant relations between: antimetabolite chemotherapeutics and feeling irritable and worrying (p=0.001, p=0.030); vinkoalkaloid and numbness/tingling in hands/feet (p=0.043); antracyclines and lack of energy and skin changes (p=0.021, p=0.004); and corticosteroids and lack of appetite, nausea and sadness (p=0.008, p=0.009, p=0.009). Several symptoms such as feeling sad, worrying and feeling irritable caused a significant decrease in the total domain of quality of life scores (p=0.034, p=0.012, p=0.010, respectively). Chemotherapeutic drugs can cause symptoms that can seriously affect quality of life in children. | en_US |
dc.description.sponsorship | Selcuk University Scientific Research Project UnitSelcuk University | en_US |
dc.description.sponsorship | The authors are grateful to Mehmet Orman in statistical analysis, and all children and their parents who participated in this study. This study was presented as poster paper in the 5th Europaediatrics Congress on June 23rd-26th in Wien, Austria. Poster report received external funding from Selcuk University Scientific Research Project Unit. | en_US |
dc.identifier.doi | 10.7314/APJCP.2013.14.3.1761 | en_US |
dc.identifier.endpage | 1768 | en_US |
dc.identifier.issn | 1513-7368 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 23679270 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1761 | en_US |
dc.identifier.uri | https://dx.doi.org/10.7314/APJCP.2013.14.3.1761 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/29763 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wos | WOS:000319985400032 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | ASIAN PACIFIC ORGANIZATION CANCER PREVENTION | en_US |
dc.relation.ispartof | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Children | en_US |
dc.subject | cancer | en_US |
dc.subject | chemotherapy | en_US |
dc.subject | symptoms | en_US |
dc.subject | quality of life | en_US |
dc.subject | Turkey | en_US |
dc.title | Quality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapy | en_US |
dc.type | Article | en_US |